FIELD: biotechnology; medicine.
SUBSTANCE: present invention relates to molecular immunology, biotechnology and medicine. Recombinant variants of a single-domain antibody (VHH) are presented, which specifically binds human interleukin-6 (IL-6) and is characterized by amino acid sequences. Single-domain antibodies disclosed herein are obtained on basis of antigen-recognizing antibody domains of lamp (Lama glama).
EFFECT: present invention can find further application in diagnosing and treating IL-6-mediated diseases.
3 cl, 4 dwg
Authors
Dates
2016-11-27—Published
2015-10-26—Filed